An earmark of $100,000 has been added to the House's fiscal year 2020 appropriation for the US Food and Drug Administration to determine a safe level of cannabidiol for use in food and dietary supplements.
FDA Appropriation Targets $100,000 To Find Safe CBD Level In Supplements
Rep. McNerneny's amendment calls for process that would follow steps FDA used in exercising enforcement discretion on natural products that contain levels of an approved drug ingredient, with red yeast rice most notable. But critics of FDA's VMS industry oversight don't see McNerney's amendment as effective not only for strengthening FDA's overall regulation but also for solving its CBD problem.